incentive schemesとは 意味・読み方・使い方

However, while institutions analysis looks mainly at the incentive schemes as offered to various entities including both individuals and organizations (companies, universities, government,etc.) and the balance brought about by their strategic behavior and its standardization, the interest of the new spatial economic analysis of agglomerations lies with the spatial aspects arising from the driving force to agglomerate (this force can be negative, in which case it works against agglomeration) brought about by various entities and by parameters such as transport costs in their broad sense.例文帳に追加

ただし、制度分析が専ら、各主体（個人、組織（企業、大学、政府等））に示されるインセンティブ・スキームと、それら主体間の戦略的行動がもたらす均衡やその規範化といった論点を考察するのに対し、集積に関する新しい空間経済学的分析は、多様な主体がもらたす集積力（正負の双方があり得る。負の場合は排斥力となる。）や広義の輸送費等のパラメータが織りなす、空間的な様相に関心がある。 - 経済産業省

Under the tax scheme for total experimental research costs established in 2003 (the research and development tax incentive scheme allowing fixed rate tax relief on total experimental research costs; made a permanent measure in 2006) the maximum relief is 20% of current term corporation tax, but the scheme is underused since the majority of pharmaceutical companies are fully up to this limit. Furthermore, although in 2006 the relief rate for the incremental tax scheme for experimental research was reduced, allowing the tax scheme for total experimental research costs or other schemes to be topped up, this measure is similarly underused due to the constraint of the 20% maximum corporation tax relief.例文帳に追加

2003 年に創設された総額試験研究税制（試験研究費の総額について一定割合を税額控除できる研究開発促進税制。2006 年に恒久措置。）は、控除限度額が当期の法人税額の 20％であり、多くの製薬企業においては控除限度額に達してしまうため、当該税制を十分に活用できていない。さらに、2006 年に増加試験研究税制の控除率が縮小され、総額試験研究税制等への上乗せを可能としたが、法人税額 20％という控除限度額内での措置のため、同様に十分活用できていない。 - 厚生労働省